Intellectual Property Magazine
Gilead’s Indian Covid-19 drug licensees to set own prices
Ben Wodecki
US biopharmaceutical company Gilead will allow Indian-basedlicensed manufacturers to set their own prices for the potential Covid-19vaccine remdesivir, it has been reported.